Sight Sciences grants RSUs to director Fountain

Fountain Tamara reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Fountain Tamara reported acquisition or exercise transactions in this Form 4 filing.

Sight Sciences director Tamara Fountain received an equity grant in the form of restricted stock units. She was awarded 28,261 RSUs on June 4, 2026 under the company’s Non-Employee Director Compensation Program, representing approximately $130,000 of common stock based on the closing price that day.

The RSUs vest on the earlier of June 4, 2027 and the company’s 2027 annual meeting of stockholders, subject to her continued board service. Following this grant, she holds 109,650 shares and units in total, including 81,389 shares of common stock and 28,261 unvested RSUs.

Insider Trade Summary

Grant/Award: 28,261 shares

Grant/Award 1 txn

Insider Fountain Tamara

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,261	$0.00	$0.00

Holdings After Transaction: Common Stock — 109,650 shares (Direct)

Footnotes (2)

1. F1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
2. F2. Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein.

Key Figures

RSUs granted: 28,261 RSUs Grant value: $130,000 Holdings after transaction: 109,650 shares/units +3 more

6 metrics

RSUs granted 28,261 RSUs Award under Non-Employee Director Compensation Program on June 4, 2026

Grant value $130,000 Approximate value of RSUs based on closing price on June 4, 2026

Holdings after transaction 109,650 shares/units Total common stock and RSUs following the grant

Common stock held 81,389 shares Shares of Sight Sciences common stock held after the grant

Unvested RSUs 28,261 RSUs RSUs subject to vesting reported in this filing

Vesting date June 4, 2027 or 2027 annual meeting RSUs vest on earlier of these dates, subject to continued service

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, vest, annual meeting of stockholders

4 terms

restricted stock units ("RSUs") financial

"Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program"

vest financial

"The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"the date of the Issuer's 2027 annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sight Sciences (SGHT) director Tamara Fountain receive in this Form 4?

Tamara Fountain received an equity grant of restricted stock units. The filing reports 28,261 RSUs awarded under Sight Sciences’ Non-Employee Director Compensation Program, representing about $130,000 in common stock value based on the June 4, 2026 closing share price.

How many Sight Sciences (SGHT) RSUs were granted and what is their value?

The grant consists of 28,261 restricted stock units. According to the filing, the number of RSUs equals approximately $130,000 of Sight Sciences common stock, calculated using the closing share price on the June 4, 2026 grant date.

When do Tamara Fountain’s Sight Sciences (SGHT) RSUs vest?

The RSUs vest in 2027, subject to continued service. They vest on the earlier of June 4, 2027 and Sight Sciences’ 2027 annual meeting of stockholders, provided Fountain remains a director on the company’s board through that vesting date.

How many Sight Sciences (SGHT) shares and RSUs does Tamara Fountain hold after this grant?

Her total reported holdings rise to 109,650 units and shares. This includes 81,389 shares of Sight Sciences common stock and 28,261 RSUs that are subject to future vesting, as detailed in the Form 4 footnotes.

Is Tamara Fountain’s Sight Sciences (SGHT) RSU grant an open-market purchase?

No, this is a compensation-related stock unit award. The transaction is coded as a grant or award acquisition (Code A), with a per-share price of $0.00, reflecting director compensation rather than an open-market stock purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fountain Tamara

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		28,261(1)	A	$0.00	109,650(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.

2. Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein.

	/s/Jeremy Hayden, Attorney-in-Fact for Tamara Fountain	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)